Stroke Flashcards
ADP receptor antagonists; name them
ticagrelor, clopidogrel, prasugrel
indications of ADP receptor antagonists
- treat ACS
- prevent occlusion of coronary artery stents
- 2* prevention of thrombotic events in those with CVS, cerebrovascular and PAD
MOA of ADP receptor antagonists
- prevent platelet aggregation and reduce risk of arterial occlusion by binding irreversibly to ADP receptors of plts. It is dependant on COX pathway so works well with aspirin
SE of ADP receptor antagonits
bleeding
GI upset including dyspepsia, abdo pain and diarrhoea.
thrombocytopenia
who should you not prescribe ADP receptor antagonists to?
- active bleeders
- stop 7 days before elective surgery
who should you use ADP receptor antagonists cautiously in
renal and hepatic impairment especially in those who have increased risk of bleeding
Clopidogrel = pro drug. reduced efficacy by what drugs
cyp 450 inhibitors;
- Omeprazole, ciprofloxacin, erythromycin, some SSRI and antifungals.
what PPI do you not give with clopidogrel
omeprazole
is prasugrel a pro drug
yes
is ticagrelor a pro drug, and what are its interactions
- no
- cyp 450 inhibitors and inducers.
what should you not prescribe ADPR receptor antagonists with
- other anticoagulants e.g. heparin or NSAIDs or antiplatelets
how long do you carry on dual antipaltelet therapy for in drug eluting stents
12months
Aspirin MOA
Antiplatelet drug
- irreversible inhibition of COX to reduce plt aggregation and risk of arterial occlusion . Antiplt effect of aspirin = low doses and lasts lifetime of plt.
Aspirin indications
- ACS and acute ischaemic stroke
- LTM secondary prevention of thrombotic arterial events in patients with CVS, Cerebrovascular and PAD
- less used now but - mild to moderate pain and fever
SE of aspirin
GI irritation;
peptic ulcer;
GI bleed
hypersensitivity reactions - bronchospas,
high dose and regular? tinnitus